Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway

Y. Ueoka, Kiyoko Kato, Y. Kuriaki, S. Horiuchi, Y. Terao, J. Nishida, H. Ueno, N. Wake

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. (C) 2000 Cancer Research Campaign.

Original languageEnglish
Pages (from-to)891-899
Number of pages9
JournalBritish Journal of Cancer
Volume82
Issue number4
Publication statusPublished - 2000

Fingerprint

Hepatocyte Growth Factor
Ovarian Neoplasms
Carcinoma
MAP Kinase Kinase Kinases
Phosphatidylinositol 3-Kinases
Morphogenesis
Mitogens
Adenoviridae
Intercellular Signaling Peptides and Proteins
Phosphotransferases
Epithelial Cells
Peptides
Infection

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Ueoka, Y., Kato, K., Kuriaki, Y., Horiuchi, S., Terao, Y., Nishida, J., ... Wake, N. (2000). Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. British Journal of Cancer, 82(4), 891-899.

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. / Ueoka, Y.; Kato, Kiyoko; Kuriaki, Y.; Horiuchi, S.; Terao, Y.; Nishida, J.; Ueno, H.; Wake, N.

In: British Journal of Cancer, Vol. 82, No. 4, 2000, p. 891-899.

Research output: Contribution to journalArticle

Ueoka, Y, Kato, K, Kuriaki, Y, Horiuchi, S, Terao, Y, Nishida, J, Ueno, H & Wake, N 2000, 'Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway', British Journal of Cancer, vol. 82, no. 4, pp. 891-899.
Ueoka, Y. ; Kato, Kiyoko ; Kuriaki, Y. ; Horiuchi, S. ; Terao, Y. ; Nishida, J. ; Ueno, H. ; Wake, N. / Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. In: British Journal of Cancer. 2000 ; Vol. 82, No. 4. pp. 891-899.
@article{234315f6cf5c4efbaec4b84851b70537,
title = "Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway",
abstract = "Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. (C) 2000 Cancer Research Campaign.",
author = "Y. Ueoka and Kiyoko Kato and Y. Kuriaki and S. Horiuchi and Y. Terao and J. Nishida and H. Ueno and N. Wake",
year = "2000",
language = "English",
volume = "82",
pages = "891--899",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway

AU - Ueoka, Y.

AU - Kato, Kiyoko

AU - Kuriaki, Y.

AU - Horiuchi, S.

AU - Terao, Y.

AU - Nishida, J.

AU - Ueno, H.

AU - Wake, N.

PY - 2000

Y1 - 2000

N2 - Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. (C) 2000 Cancer Research Campaign.

AB - Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. (C) 2000 Cancer Research Campaign.

UR - http://www.scopus.com/inward/record.url?scp=0033965252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033965252&partnerID=8YFLogxK

M3 - Article

C2 - 10732763

AN - SCOPUS:0033965252

VL - 82

SP - 891

EP - 899

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -